Search Within

Sean McCarthy Devlin

  1. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (75)
  2. Journal Article (40)
Groups
  1. Biostatistics Service (115)
  2. Center for Hematologic Malignancies (115)
  3. Department of Medicine (115)
  4. Epidemiology and Biostatistics (115)
  5. Hematologic Malignancies, Division of (115)
  6. Immunology Program Faculty (115)

More Groups

People
  1. Sergio Giralt (103)
  2. Miguel-Angel Perales (101)
  3. Marcel Van Den Brink (77)
  4. Richard O'Reilly (68)
  5. Molly Maloy (65)
  6. Ann Jakubowski (61)

More People

Years
  1. 2023 (3)
  2. 2022 (8)
  3. 2021 (6)
  4. 2020 (10)
  5. 2019 (10)
  6. 2018 (15)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (46)
  2. Blood (34)
  3. Bone Marrow Transplantation (10)
  4. Blood Advances (5)
  5. Journal of Clinical Oncology (3)
  6. Haematologica (2)

More Publications

Publishers
  1. Elsevier Inc. (47)
  2. American Society of Hematology (39)
  3. Nature Publishing Group (12)
  4. American Association for the Advancement of Science (3)
  5. American Society of Clinical Oncology (3)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (115)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive mutational profiling in myelodysplastic syndromes treated with decitabine and tretinoin
    Meeting Abstract

    Shih, A. H.; Devlin, S. M.; Dolezal, E. K.; Knapp, K. M.; Wang, K.; Sanford, E. M.; Brennan, T.; Yelensky, R.; Nahas, M.; Otto, G. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Outcomes in patients with acute lymphoblastic leukemia in first or second complete remission receiving ex-vivo T-cell depleted or unmodified allografts: Comparison of results at two institutions
    Meeting Abstract

    Hobbs, G. S.; Hilden, P.; Hamdi, A.; Goldberg, J. D.; Poon, M.; Ledesma, C.; Devlin, S.; Rondon, G.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Mutational profiling of myeloid malignancies for prediction of disease relapse following allogeneic stem cell transplantation
    Meeting Abstract

    Hanash, A. M.; Devlin, S. M.; Maloy, M.; Knapp, K. M.; Miller, V. A.; Lipson, D.; Stephens, P. J.; Otto, G. A.; Yelensky, R.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD)
    Meeting Abstract

    Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M.; Goldberg, J. D.; Perales, M. A.; Barker, J. N.; Castro-Malaspina, H.; Koehne, G.; Ponce, D. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation combined with haplo-identical CD34+ cell-selected PBSC results in 100% CB engraftment with enhanced myeloid recovery
    Meeting Abstract

    Barker, J. N.; Ponce, D. M.; Dahi, P. B.; Devlin, S.; Evans, K. L.; Lubin, M. N.; Meagher, R.; Reich, L.; Castro-Malaspina, H.; Goldberg, J. D.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Final product composition after ex-vivo T-cell reduction: Miltenyi clinimacs versus baxter isolex 300i in a large cohort of allogeneic transplant patients
    Meeting Abstract

    Tonon, J.; Koehne, G.; Collins, N. H.; Malloy, M.; Chen, X.; Bleau, S.; Pessin, M.; Smith, K.; Maslak, P.; Devlin, S.; more...
    Cytotherapy (2013)

    Fulltext@MSK | Save
  • The prognostic significance of peripheral blood mixed chimerism after T-cell depleted allogeneic stem cell transplant
    Meeting Abstract

    Olson, A. L.; Lehrman, R.; Devlin, S.; Maloy, M.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J.; O'reilly, R.; Perales, M. A.; Papadopoulos, E.; more...
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Incidence, nature, risk factors and outcomes of cytomegalovirus infection after double-unit cord blood transplantation
    Meeting Abstract

    Dahi, P.; Olson, A. L.; Devlin, S.; Lubin, M.; Gonzales, A. M.; Evans, K.; Scaradavou, A.; Kernan, N.; Small, T.; O'reilly, R.; more...
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save